Načítá se...
Comparable Efficacy and Safety of Insulin Glulisine and Insulin Lispro When Given as Part of a Basal–Bolus Insulin Regimen in a 26-Week Trial in Pediatric Patients with Type 1 Diabetes
BACKGROUND: We compared the efficacy and safety of insulin glulisine with insulin lispro as part of a basal–bolus regimen in children and adolescents with type 1 diabetes. METHODS: Overall, 572 children and adolescents (4–17 years old) using insulin glargine or neutral protamine Hagedorn insulin as...
Uloženo v:
| Hlavní autoři: | , , , , , |
|---|---|
| Médium: | Artigo |
| Jazyk: | Inglês |
| Vydáno: |
Mary Ann Liebert, Inc.
2011
|
| Témata: | |
| On-line přístup: | https://ncbi.nlm.nih.gov/pmc/articles/PMC3045789/ https://ncbi.nlm.nih.gov/pubmed/21291333 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1089/dia.2010.0072 |
| Tagy: |
Přidat tag
Žádné tagy, Buďte první, kdo otaguje tento záznam!
|